Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source
DOACs vs warfarin in AF with comorbid CKD or valvular disease: a systematic review and meta-analysis. [PDF]
Liang A +3 more
europepmc +1 more source
Usefulness of cardiac hormones for evaluating valvular disease in cynomolgus monkeys (Macaca fascicularis). [PDF]
Pai C +8 more
europepmc +1 more source
ABSTRACT Background There are limited data evaluating the association between operator−patient sex, and outcomes in patients undergoing percutaneous coronary intervention (PCI). Methods We included 138,112 consecutive PCI procedures in patients presenting with acute coronary syndrome (ACS) in England and Wales, 2017−2020.
Sharon A. Ayayo +6 more
wiley +1 more source
Oxidized Phospholipids and Calcific Aortic Valvular Disease. [PDF]
Bhatia HS +16 more
europepmc +1 more source
Tricuspid Annulus Dilation in Patients With Combined Functional Tricuspid Regurgitation and Left-Heart Valvular Disease: Does Septal Annulus Not Dilate? [PDF]
Teng P +6 more
europepmc +1 more source
Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age
ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens +8 more
wiley +1 more source
ABSTRACT Background Vascular access site complications (VASCs) remain an important source of morbidity following percutaneous interventions. Although the sheath‐to‐femoral artery ratio is a recognized risk factor in transcatheter aortic valve implantation (TAVI), its role across a broader range of femoral procedures is less well defined.
Eduardo Ismael Arteaga Chan +2 more
wiley +1 more source
Patient with valvular disease: evolving care patterns. [PDF]
Lurz P, Senni M, Guérin P.
europepmc +1 more source
Challenge of a therapeutic sequence: rare case of heart failure in mitral valvular disease intensified by an extreme mediastinal shift from major diaphragmatic eventration. [PDF]
Le Pimpec-Barthes F +3 more
europepmc +1 more source

